undefined undefined
NaN.000
NaN.00%
92% (12/13) overall response rate (ORR) for relapsed/refractory AL Amyloidosis patients enrolled in NEXICART-1: 12 out of 12 patients not exposed to prior BCMA-targeted bispecific responded to NXC-201 (100% ORR), of
05-10 21:36
NexImmune(NEXI.US):2023年Q4财报实现营收0美元,前值为0美元;每股收益为-4.99美元,前值为-16.25美元。
04-17 07:20
Companies in the Technology sector have received a lot of coverage today as ana...
04-07 17:05
Gainers: MediaCo Holding (MDIA) +200%. 22nd Century Group (XXII) +98%. Better Choice Company (BTTR) +77%. Hub Cyber Security (HUBC) +46%. GCT Semiconductor (GCTS) +38%. Grindrod Shipping (GRIN) ...
04-06 02:55
Immix Biopharma, Inc. (NASDAQ:IMMX), a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today announced its 12-month progress update including shareholder letter. "The
02-21 22:39
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading. 4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150 demonstrating favorable tolerability & clinical activity in wet AMD.
02-05 21:04
NexImmune Announces $3.67M Registered Direct Offering Of 304,731 Shares At $12....
02-03 03:02
CRBP隔夜大涨逾35%,获股东增持28.26万股普通股股份;Kura肿瘤学收涨12.1%,公司对白血病联合疗法的研究早期数据积极>>
01-31 19:15
瞻博网络大涨21.8%,获慧与科技140亿美元收购;Sarepta治疗隔夜涨16.7%,公司预计2023年全年收入为11.5亿美元>>
01-10 19:51